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Objective: Endoscopic resection of sinonasal squamous cell carcinoma has become the standard of care, but challenges
remain in obtaining clear resection margins. The current study evaluated the feasibility of endoscopic fluorescence-guided sur-
gery (FGS) to improve surgical resection in a human sinus surgical model.
Methods: A fluorescence endoscope optimized for near-infrared (NIR) fluorescence detection was evaluated in a phantom
study. Various endoscope diameters (4 and 10 mm) and viewing angles (0, 30, and 45 degrees) were evaluated to determine
the sensitivity of the system for IRDye800CW detection at various working distances (1–5 cm). Endoscopic FGS was then vali-
dated in a three-dimensional human sinus surgical model to which squamous cell tumors derived from mice were inserted.
Mice had received intravenous panitumumab-IRDye800CW and upon fluorescence-guided tumor resection, mean fluorescence
intensity (MFI) and tumor-to-background ratio (TBR) were calculated in in situ and ex vivo settings.
Results: A significantly higher fluorescence intensity was found when using the 10-mm diameter endoscope compared to
the 4mm diameter endoscope (P < .001). No significant difference in MFI was found among the viewing angles of the 4-mm
diameter endoscope. Using the human sinus model, the highest MFI and TBR were obtained at a 1-cm working distance com-
pared to longer working distances.
Conclusion: We demonstrate that clinically acceptable TBRs were obtained with several working distances to discrimi-
nate tumor tissue from adjacent normal tissue in a human sinus model, and that endoscopic FGS may have great potential in
identifying residual tumor tissue regions during surgery.
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INTRODUCTION
Sinonasal squamous cell carcinoma (SNSCC) is the
most common histology in malignant sinonasal tumors.1,2
Surgical resection is considered the standard of care treat-
ment for SNSCC, and complete resection with tumor-free
margins provides optimal survival.3 Recent studies have
demonstrated the usefulness and feasibility of an endo-
scopic approach for malignant sinonasal tumors with
acceptable survival outcomes and low rate of surgical
complications.4–6 However, while endoscopy allows for
minimally invasive surgery and direct visualization of the
surgical field, clear resection margins can be difficult to
ascertain due to a narrow field of view and the inability to
palpate tumor edges. Consequently, rates of positive mar-
gins for endoscopic surgery for SNSCC are high (22–30%),
which can result in increased local recurrence and
decreased survival.7,8
Fluorescence-guided surgery (FGS) is increasingly
being studied as a guide to differentiate tumor tissue from
normal tissue in an intraoperative setting.9 Although sev-
eral agents are under active clinical study,10–13 we investi-
gated the anti-epidermal growth factor receptor (EGFR)
antibody-dye conjugate panitumumab-IRDye800CW, which
has demonstrated a high sensitivity and specificity of squa-
mous cell carcinoma (SCC) detection in patients with head
and neck cancer.14–18 We hypothesize that translating this
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technique to endoscopic surgery may improve discrimina-
tion of tumor tissue from adjacent normal tissue. This
would ultimately allow for more precise visualization of the
tumor margins and reduce incomplete tumor resection.
Thus, the objective of this study was to evaluate the poten-
tial clinical utility of the endoscopic sinonasal FGS tech-
nique in a novel human sinus surgical model and to
determine the optimal surgical conditions for fluorescence
detection.
MATERIALS AND METHODS
Endoscopic Fluorescence Imaging System
The endoscopic near-infrared (NIR) fluorescence imaging
system included a D-Light P Xenon light source with ICG filters
and an Image1S H3-Z FI camera. Other components on the
device were the Image1 S connect platform, the Image1 S
H3-link, a Storz Aida HD Connect, and a fiber optic light cable
connecting the light source and rigid Hopkins telescopes (KARL
STORZ SE & Co KG, Tuttlingen, Germany). Using a foot-switch,
the system allows a switchover between fluorescence and stan-
dard white light mode.
Shown in Figure 1 are the endoscopes that were evaluated.
Three 4-mm diameter, 18-cm long endoscopes (0, 30, and
45 degrees) and two 10-mm diameter, 31-cm long, endoscopes
(0 and 30 degrees) were evaluated. All of the endoscopes had
built-in filters for NIR light detection, with the detected fluores-
cence signal being displayed on-screen as a blue signal overlaid
onto a bright field image. Images taken with the endoscopic
imaging device were compared with a closed-field fluorescence
imaging-device (Pearl Trilogy Imaging System; LI-COR Biosci-
ences Inc., Lincoln, NE, USA). The closed-field device shields
itself from ambient light, allowing for consistent fluorescence
imaging and served as a “gold-standard” fluorescence imaging
device in this study, in a manner similar to as previously
reported.18
Sensitivity to IRDye800CW
To determine the sensitivity of the device to NIR fluores-
cence detection of panitumumab-IRDye800CW, a 20-step 1:2
dilution range, ranging 4.58 mM to 3.94 pM, was generated of
IRDye800CW carboxylate (LI-COR Biosciences Inc.) in water.
For reference, the dilution range was first measured in the
closed-field imaging device. Subsequently, the three rigid 4mm
diameter endoscopes (0, 30, and 45 degrees; Fig. 1) and two
10-mm diameter endoscopes (0 and 30 degrees) were used to
measure fluorescence signals for all concentrations of dye to
determine, quantitatively and qualitatively, the sensitivity of the
device, in a manner similar to as previously reported.19 To deter-
mine the optimal working distance of the endoscope (ie, the
working distance at which the highest sensitivity was reached)
the experiment was performed at working distances rang-
ing 1–5 cm.
Endoscopic Sinus Surgery Model
Nude (nu/nu) female mice, aged 6–8 weeks (Charles River
Laboratories, Wilmington, MA, USA), were obtained and housed
in accordance with our Institutional Animal Care and Use Com-
mittee (IACUC) guidelines. All experiments were conducted after
review and approval of the institution’s IACUC guidelines. To
generate the orthotopic head and neck squamous cell carcinoma
(HNSCC) model, mice (n = 4) were injected with SCC-1 cells
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Fig. 1. IRDye800CW sensitivity testing of an endoscopic fluorescence imaging system. A) top: Phantom setup; bottom: Fluorescence signal
intensities as detected with the 4-mm diameter endoscope (0 degree) at various working distances (1–5 cm). B) top: Tested 4-mm diameter,
18-cm long, endoscopes with 0, 30, and 45 degrees; bottom: 4-mm diameter endoscopes (0, 30, 45 degrees) were evaluated at 2 cm working
for their sensitivity in detecting IRDye800CW. C) top: Visual impression of the fluorescence signal detected with 0 degree, 4-mm diameter
endoscope; bottom: Fluorescence signals (MFI) detected with 4-mm diameter endoscope (0 degree) was plotted against the MFIs measured
with the closed-field imaging device. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
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mouth using a 30-G insulin syringe. Tumor growth was followed
for 2–3 weeks by direct visual inspection and palpation, after
which the mice were systemically injected with 100 μg of GMP-
produced panitumumab-IRDye800CW.14 Mice were sacrificed
48 hours post-injection after which the skin overlying the floor of
the mouth was removed and imaging in the closed-field device
was performed to verify presence of panitumumab-IRDye800CW.
In order to simulate the anatomic and light conditions of
SNSCC resection, sacrificed mice were placed in an anatomically
accurate three-dimensional sinus model (sinus model otorhino
neuro trainer; Pro Delphus, Pernambuco, Brazil).20 An overview
of the experimental setup is given in Figure 2. Tumors were then
resected under guidance of the endoscopic imaging using the
0 degree, 4-mm diameter, endoscope whereby various working
distances (1, 2, and 3 cm) were assessed. Upon completion of
resection, a second closed-field fluorescence image was acquired
to verify the complete removal of the tumor tissue.
To determine the smallest detectable size of tumor tissue,
excised tumor tissue and normal muscle were divided into parts,
varying in weight from 0.2 to 20 mg (Fig. 5). Each piece was
imaged using the fluorescence endoscopic imaging device, and for
verification, each piece was also imaged in the closed-field device.
Histopathology
During resection of the tumor tissue from the mice, repre-
sentative primary tumor tissue, tumor-to-normal margin tissue
and wound-bed tissue was collected, formalin-fixed and paraffin
embedded, after which blank slides (4-μm thickness) were
obtained for a hematoxylin and eosin (H&E) stain. Subsequent
immunohistochemistry was also conducted to assess for epidermal
growth factor (EGFR) expression using an anti-EGFR antibody
(clone EP38Y, Thermo Fisher Scientific, Waltham, MA, USA).14
Fluorescence Microscopy
For fluorescence microscopy, selected tissue slides were
deparaffinized, and the nuclei were counterstained with
4’,6-diamidino-2-phenylindole (DAPI, Prolong Diamond, Thermo
Fisher Scientific). Stained slides were dried overnight, in the
dark, and imaged using a custom setup inverted digital fluores-
cence microscope (DM6B, Leica Biosystems, Wetzlar, Germany)
equipped with a highly sensitive Leica DFC9000GT camera
(4.2-M pixel sCMOS camera), a metal halide LED light source
(X-Cite 200DC, Excelitas Technologies, Waltham, MA, USA) for
DAPI imaging, and a xenon arc lamp LB-LS/30 (Sutter Instru-
ment, Novato, CA, USA) for NIR imaging of IRDye800CW. Image
acquisition and processing was done using LAS X software (Leica
Biosystems).
Image Quantification and Data Analysis
Endoscopic images that were acquired before, during, and
after tumor resection were loaded into ImageJ (National Insti-
tutes of Health, Bethesda, MD, USA) to quantitatively assess the
fluorescence signal in situ and ex vivo. Because the endoscopic
imaging system presents the fluorescence signal as an overlay
image whereby the fluorescence signal (in blue) is overlaid on the
bright field image, acquired images were split into RGB color
channels in ImageJ. Subsequently, the blue channel of each
image was analyzed in ImageJ as being the “raw” fluorescence
signal. Reference (“gold standard”) images acquired with the
closed-field fluorescence-imaging device were analyzed using
Image Studios software (LI-COR Biosciences Inc.).
For fluorescence signal quantification in both ImageJ and
Image Studio, regions of interest (ROIs) were drawn around the
area of interest and mean fluorescence intensities (MFIs, a.u.)
were calculated. Tumor-to-background ratios (TBRs) were calcu-
lated by dividing tumor MFI by the normal tissue MFI.
Statistical Analysis
Descriptive statistics was performed using GraphPad Prism
software (Version 6.0c; GraphPad Software, La Jolla, CA, USA).
Data is presented as means with standard deviations for continu-
ous variables. To compare the endoscope variants (diameter and
Fig. 2. Clinically relevant surgical sinus model. Left: Three-dimensional sinus model—components of the sinus model with two endoscopic
images. S = septum; I = inferior turbinate; M = middle turbinate. Right: Fluorescence-guided surgery—representative images acquired with the
4-mm diameter endoscope (0 degree). Bright field (top) and fluorescence images (bottom) are collected with the endoscope. [Color figure can
be viewed in the online issue, which is available at www.laryngoscope.com.]














































































Fig. 3. Fluorescence signals and tumor-to-background ratio in situ and ex vivo setting measured at three working distances (1–3 cm). Images
taken by the endoscopic fluorescence imaging system of in situ (A) and ex vivo (B) normal muscle and tumor tissue at three working distances
(1–3 cm). [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
Fig. 4. Fluorescence-guided resection of tumor. Using the 4mm diameter endoscope (0 degrees), fluorescence and bright field images were
acquired prior to resection, after initial resection, and after re-resection of residual tumor. Histopathology confirmed presence of EGFR in the
excised tumor tissue, but not in the normal tissue. Via fluorescence microscopy presence of panitumumab-IRDye800CW was confirmed in the
tumor tissue. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
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degree) in the phantom study, Wilcoxon matched-pairs signed
rank test or Friedman test were used. Mann–Whitney U test
was used for comparison of the tumor MFIs and normal tissue
MFIs. Exponential regression analysis was performed on data
comparing the two imaging systems. A P-value of .05 or less was
considered statistically significant.
RESULTS
Ex-vivo Fluorescence Endoscopy Validation
Three 4-mm diameter endoscopes of varying angles of
view (0, 30, and 45 degrees) were used to image the dilution
range of 20 concentrations of IRDye800CW at five working
distances ranging 1–5 cm to evaluate the sensitivity of the
endoscopes. For the 4-mm diameter endoscope (0 degree),
the highest and most reliable fluorescence signals were
obtained at the 2-cm working distance (Fig. 1A); therefore,
we determined 2 cm as the optimal working distance for
our phantom study. In terms of the degree of 4mm diame-
ter endoscopes, no differences were found in MFI when
changing the angle of the endoscope (0, 30, and 45 degree;
P = .17, Fig. 1B). Visually, at a working distance of 2 cm,
the lowest concentration of dye that produced a visible fluo-
rescence signal in the raw images was 698 nM (Fig. 1C).
Fluorescence imaging data obtained with the endoscopic
device strongly correlated to that of the closed-field imaging
device (R2 = 0.99, Fig. 1C), which indicated the robustness
of the endoscopic fluorescence imaging system. When com-
paring between 4-mm and 10-mm diameter endoscopes, a
significantly higher MFI was found when using the 10-mm
diameter endoscope (P < .001, Supplementary Fig. 1).
Fluorescence Endoscopy Discriminates Tumor
Tissue from Adjacent Surrounding Normal
Tissue
To recreate the clinical environment, an in situ sinus
model was employed and using the 0 degree, 4-mm diameter
endoscope we studied tumor visibility at various working dis-
tances (1–3 cm) and analyzed the tumor MFI and TBR in situ
and ex vivo. In situ, a higher tumor MFI was found at the
1-cm working distance compared to the 2- or 3-cm working
distances (mean MFI 131.6 a.u. vs. 108.0 a.u. and 82.6 a.u.),
but similar TBRs were obtained for the three working dis-
tances (mean 5.2, 4.6, and 4.8, respectively) (Fig. 3A). Similar
results were found, ex vivo, where tumors were imaged out-
side of the sinus model. Ex vivo, the MFI was also found to be
highest at a working distance of 1 cm compared to the 2- or
3-cm working distances (mean; 110.5 a.u. vs. 75.4 a.u. and
51.6 a.u.) with TBR decreasing with increasing working dis-
tance (mean 3.7, 3.4, and 3.0, respectively) (Fig. 3B).
Fluorescence Endoscopy Identifies Residual
Tumor Deposits
Using the human sinus model, the potential value of
endoscopic FGS for tumor visualization and margin
assessment for sinonasal surgery was assessed. Following
tumor visualization (Fig. 4), an incomplete tumor re-
section was performed to evaluate whether or not the
imaging device was sensitive enough to pick up residual
tumor. As can be seen in Figure 4, residual tumor
deposits could be clearly visualized and subsequently
removed. In further assessment of excised tumor tissue
pieces, the smallest piece of tumor tissue (0.6 mg) had a
visible fluorescence signal and could be discriminated
from normal tissue (Fig. 5A). A significantly higher MFI
was found for tumor tissue when compared to normal tis-
sue (mean: 40.0 vs. 15.6 a.u., P < .05, Fig. 5b), demon-
strating this technique could clearly discriminate the
tumor tissue from normal tissue even though the tumor
deposits were very small. Imaging results with the endo-
scopic device were corroborated by the closed-field imag-
ing device. Histology, including immunohistochemistry of
EGFR, confirmed the presence of tumor at areas that
were positive for fluorescence (Fig. 4).









































Fig. 5. Panitumumab-IRDye800CW uptake in tumor and normal tissue. A) Tumor and normal muscle were serially bisected into pieces, with
the smallest piece being 0.6 mg, and the fluorescence signal was imaged using the 4-mm diameter endoscope (0 degrees). The mean fluores-
cence signal (MFI) was plotted as a function of weight (mg) of both tumor (red) and normal (muscle; blue) tissue samples. B) Upon normaliza-
tion of the fluorescence signal, by dividing the measured MFI by the tissue weight, panitumumab-IRDye800CW distribution in tumor tissue
was found to be significantly higher in tumor tissue compared to normal (muscle) tissue. [Color figure can be viewed in the online issue, which
is available at www.laryngoscope.com.]
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DISCUSSION
For sinonasal cancers, complete resection with clear
margins significantly impacts oncologic outcomes in patients
treated with minimally invasive endoscopic resection.8,21
Despite the fact that intraoperative frozen margins are reli-
ably interpreted for sinonasal tumors,22 a clear demarcation
of tumor from normal tissue or inflamed polypoid tissues is
difficult within the sinonasal cavity. In the current study we
demonstrate that endoscopic fluorescence imaging can be
sensitive and specific to detect the tumor after systemic
administration of a NIR tumor-targeting agent. Moreover,
clinically relevant TBRs were obtained with several working
distances to discriminate the tumor from adjacent normal
tissue in a human sinus model, highlighting the potential of
this technique to identify residual tumor regions during sur-
gery. Results of the current study are in line with previous
studies in open-field FGS approaches for identification of
tumor in an in vivo and an ex vivo setting.15,17
The current study demonstrates that endoscopic
imaging systems with NIR fluorescence-detection designed
for ICG can be repurposed for use with IRDye800CW.
Despite the consistency of the TBR at greater working dis-
tances in our model, the fluorescent signal (measured in
MFI) was negatively correlated with working distance.
The optimal working distance is thought to lie within 1–3
cm in a clinical setting; fluorescence imaging becomes
brighter as the working distance is reduced and vice versa.
However, there is an increase in light reflection off of tis-
sue at shorter working distances, which may ultimately
obscure tumor visualization in a surgical setting.
Endoscopes used for sinus surgery or endonasal skull
base surgery generally have an outer diameter of 4 mm,
whereas endoscopes with 10-mm diameter are common in
the laparoscopic surgeries. Our results demonstrate the
applicability of the FGS technique beyond open-field and
laparoscopic applications (eg, in the abdominal cavity).
Although the fluorescence signal obtained from 4-mm
diameter endoscopes was less than the signal from 10-mm
diameter endoscopes in our phantom experiments, a
strong fluorescence signal with acceptable TBRs was
achieved in the sinus surgery model using the 4-mm diam-
eter endoscope. Interestingly, the fluorescence intensity
was consistent with 0, 30, and 45 degrees of view angle in
the phantom study, demonstrating the wide applicability
of this technique, particularly for bulky and odd-shaped
tumors.
Clinically, endoscopic FGS has emerged as a promising
technique to improve surgical precision during tumor resec-
tion. Utilizing NIR fluorescence imaging using ICG with
laparoscopic and robot-assisted surgery have improved
oncologic outcomes reported in procedures such as
hepatectomy,23 nephrectomy,24 hysterectomy,25 and gas-
trectomy.26 We and others have reported the feasibility and
potential clinical benefits of FGS using antibody dye–based
imaging for patients with solid tumors.10,11,13–18,27–31 Com-
bining FGS with the advantages of a minimally invasive,
endoscopic approach may hold the potential to reduce mor-
bidity while ensuring adequate oncologic outcomes. How-
ever, this has yet to be further investigated and validated
in large prospective trials.
CONCLUSION
We demonstrate that endoscopic imaging of a tumor-
specific NIR imaging agent can discern tumor tissue from
normal tissue in a preclinical model under a range of con-
ditions with a clinically relevant TBR at working dis-
tances from 1–3 cm.
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